Editas Medicine
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $10,365 | $11,890 | $2,831 | $24,741 |
Gross Profit | 10,365 | 11,890 | 2,348 | 24,741 |
EBITDA | -24,282 | -19,523 | -23,427 | -5,279 |
EBIT | -22,311 | -19,939 | -23,910 | -6,084 |
Net Income | -23,393 | -18,230 | -24,982 | -5,620 |
Net Change In Cash | 10,365 | 11,890 | 2,831 | 24,741 |
Free Cash Flow | -21,190 | -29,674 | -23,153 | -36,447 |
Cash | 93,169 | 181,815 | 123,648 | 146,645 |
Basic Shares | 153,604 | 119,294 | 97,879 | 88,745 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $40,520 | $32,314 | $78,123 | $19,712 |
Gross Profit | 40,520 | -166,933 | 72,059 | 19,712 |
EBITDA | -148,612 | -233,111 | -147,155 | -219,613 |
EBIT | -153,889 | -238,920 | -153,219 | -225,950 |
Net Income | -160,060 | -237,093 | -153,219 | -204,352 |
Net Change In Cash | 40,520 | 32,314 | 78,123 | 19,712 |
Cost of Revenue | -61,997 | |||
Free Cash Flow | -165,848 | -219,110 | -136,897 | -181,467 |
Cash | 146,645 | 131,541 | 123,652 | 141,522 |
Basic Shares | 88,745 | 82,338 | 75,965 | 68,664 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.15 |
2026-06-30 | -$0.15 |
2026-03-31 | -$0.26 |
2025-12-31 | -$0.06 |